Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders
- Sponsor
- Bedaya Hospital
- Study ID
- NCT07569315
- Phase
- PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Infertility
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 40 Years
- Healthy Volunteers
- Not accepted
Interventions
- Successive doses GnRH agonist — DRUGGnRH agonist ( Triptorelin ) ( 0.2 mg / S.C ) is administered 36 hours before ovum pickup. Two additional doses of triptorelin ( 0.1 mg / S.C ) are administered subcutaneously 12 and 24 hours after the first dose of GnRH agonist.
- Single dose GnRH agonist — DRUGGnRH agonist ( Triptorelin ) ( 0.2 mg / S.C ) is administered 36 hours before ovum pickup.
Study Details
The aim of this randomized controlled study is to compare the efficacy of three successive doses of a GnRH agonist ( administered 36 , 24 and 12 hours before oocyte retrieval ) with a single dose of a GnRH agonist ( administered 36 hours before oocyte retrieval ) in triggering ovulation in hyper-responders
Key Dates
- First listed
- May 6, 2026
- Start date
- Jun 1, 2026
- Status verified
- May 2026
- Primary completion
- Dec 1, 2027
- Completion
- Apr 1, 2028
Study Design
- Enrollment
- 190 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Successive doses GnRH agonistThree successive doses of GnRH agonist are administered 36 , 24 and 12 hours before oocyte retrieval
- Active Comparator: Single dose GnRH agonistA single dose of GnRH agonist is administered 36 hours before oocyte retrieval
Primary Outcome Measure
Metaphase-II oocytes rate [ Time Frame: Ten to fifteen days after starting ovarian stimulation ]
Central Contacts
- Usama M. Fouda, Prof.+201095401375
Related Studies
- Study to Create Potential Cell-Based Therapies to Treat Human Disease and DisabilityEnrolling By Invitation · Stanford University · Stanford, California
- Discarded Materials StudyRecruiting · Reproductive Medicine Associates of New Jersey · Basking Ridge, New Jersey
- Study of Gene Associations and InfertilityEnrolling By Invitation · Reproductive Medicine Associates of New Jersey · Basking Ridge, New Jersey
- Inherited Reproductive DisordersRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Bethesda, Maryland